Other Species / Isoforms
  TORC2 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
S17-p
GSATASAsNPRkFSE
0 1
TORC2 (human) GSATASAsNPRkFSE S17-p
TORC2 (mouse) GSATASASNPRKFSE S17
TORC2 (rat) GSATASASNPRKFSE S17
K21-sm
ASAsNPRkFSEkIAL
0 1
TORC2 (human) ASAsNPRkFSEkIAL K21-sm
TORC2 (mouse) ASASNPRKFSEKIAL K21
TORC2 (rat) ASASNPRKFSEkIAL K21
K25-ac
NPRkFSEkIALQkQR
0 2
TORC2 (human) NPRkFSEkIALQkQR K25-ac
TORC2 (mouse) NPRKFSEKIALQKQR K25
TORC2 (rat) NPRKFSEkIALQKQR K25-ac
K25-sm
NPRkFSEkIALQkQR
0 1
TORC2 (human) NPRkFSEkIALQkQR K25-sm
TORC2 (mouse) NPRKFSEKIALQKQR K25
TORC2 (rat) NPRKFSEKIALQKQR K25
K25-ub
NPRkFSEkIALQkQR
0 2
TORC2 (human) NPRkFSEkIALQkQR K25-ub
TORC2 (mouse) NPRKFSEKIALQKQR K25
TORC2 (rat) NPRKFSEKIALQKQR K25
K30-ub
SEkIALQkQRQAEET
0 1
TORC2 (human) SEkIALQkQRQAEET K30-ub
TORC2 (mouse) SEKIALQKQRQAEEt K30
TORC2 (rat) SEkIALQKQRQAEET K30
T37
kQRQAEETAAFEEVM
0 1
TORC2 (human) kQRQAEETAAFEEVM T37
TORC2 (mouse) KQRQAEEtAAFEEVM T37-gl
TORC2 (rat) KQRQAEETAAFEEVM T37
S64-p
LRLAYTRssHyGGsL
0 7
TORC2 (human) LRLAYTRssHyGGsL S64-p
TORC2 (mouse) LRLAYTRsSHYGGsL S64-p
TORC2 (rat) LRLAYTRsSHYGGSL S64-p
S65-p
RLAYTRssHyGGsLP
0 1
TORC2 (human) RLAYTRssHyGGsLP S65-p
TORC2 (mouse) RLAYTRsSHYGGsLP S65
TORC2 (rat) RLAYTRsSHYGGSLP S65
Y67-p
AYTRssHyGGsLPNV
0 5
TORC2 (human) AYTRssHyGGsLPNV Y67-p
TORC2 (mouse) AYTRsSHYGGsLPNV Y67
TORC2 (rat) AYTRsSHYGGSLPNV Y67
S70-p
RssHyGGsLPNVNQI
Upstream
1 62
Treatment
  • SII_angiotensin_2
TORC2 (human) RssHyGGsLPNVNQI S70-p
TORC2 (mouse) RsSHYGGsLPNVNQI S70-p
TORC2 (rat) RsSHYGGSLPNVNQI S70
S70
RssHyGGSLPNVNQI
1 1
TORC2 (human) RssHyGGSLPNVNQI S70
TORC2 (mouse) RsSHYGGsLPNVNQI S70-gl
TORC2 (rat) RsSHYGGSLPNVNQI S70
S79-p
PNVNQIGsGLAEFQs
0 6
TORC2 (human) PNVNQIGsGLAEFQs S79-p
TORC2 (mouse) PNVNQIGCGLAEFQs C79
TORC2 (rat) PNVNQIGCGLAEFQS C79
S86-p
sGLAEFQsPLHsPLD
0 43
TORC2 (human) sGLAEFQsPLHsPLD S86-p
TORC2 (mouse) CGLAEFQsPLHsPLD S86-p
TORC2 (rat) CGLAEFQSPLHSPLD S86
S90-p
EFQsPLHsPLDsSRS
0 39
TORC2 (human) EFQsPLHsPLDsSRS S90-p
TORC2 (mouse) EFQsPLHsPLDSSRS S90-p
TORC2 (rat) EFQSPLHSPLDSSRS S90
S94-p
PLHsPLDsSRSTRHH
0 1
TORC2 (human) PLHsPLDsSRSTRHH S94-p
TORC2 (mouse) PLHsPLDSSRSTRHH S94
TORC2 (rat) PLHSPLDSSRSTRHH S94
R106-m1
RHHGLVErVQRDPRR
0 1
TORC2 (human) RHHGLVErVQRDPRR R106-m1
TORC2 (mouse) RHHGLVERVQRDARR R106
TORC2 (rat) RHHGLVERVQRDPRR R106
S116-p
RDPRRMVsPLRRYTR
0 6
TORC2 (human) RDPRRMVsPLRRYTR S116-p
TORC2 (mouse) RDARRMVSPLRRyPR S116
TORC2 (rat) RDPRRMVSPLRRYPR S116
Y121
MVsPLRRYTRHIDss
0 1
TORC2 (human) MVsPLRRYTRHIDss Y121
TORC2 (mouse) MVSPLRRyPRHIDss Y121-p
TORC2 (rat) MVSPLRRYPRHIDSS Y121
S127
RYTRHIDSsPysPAy
0 1
TORC2 (human) RYTRHIDSsPysPAy S127
TORC2 (mouse) RyPRHIDssPySPAY S127-gl
TORC2 (rat) RYPRHIDSSPYSPAY S127
S127-p
RYTRHIDssPysPAy
1 2
TORC2 (human) RYTRHIDssPysPAy S127-p
TORC2 (mouse) RyPRHIDssPySPAY S127-p
TORC2 (rat) RYPRHIDSSPYSPAY S127
S128
YTRHIDsSPysPAyL
0 1
TORC2 (human) YTRHIDsSPysPAyL S128
TORC2 (mouse) yPRHIDssPySPAYL S128-gl
TORC2 (rat) YPRHIDSSPYSPAYL S128
S128-p
YTRHIDssPysPAyL
0 2
TORC2 (human) YTRHIDssPysPAyL S128-p
TORC2 (mouse) yPRHIDsSPySPAYL S128
TORC2 (rat) YPRHIDSSPYSPAYL S128
Y130-p
RHIDssPysPAyLsP
0 5
TORC2 (human) RHIDssPysPAyLsP Y130-p
TORC2 (mouse) RHIDssPySPAYLsP Y130-p
TORC2 (rat) RHIDSSPYSPAYLSP Y130
S131-p
HIDssPysPAyLsPP
0 12
TORC2 (human) HIDssPysPAyLsPP S131-p
TORC2 (mouse) HIDssPySPAYLsPP S131
TORC2 (rat) HIDSSPYSPAYLSPP S131
Y134-p
ssPysPAyLsPPPES
0 14
TORC2 (human) ssPysPAyLsPPPES Y134-p
TORC2 (mouse) ssPySPAYLsPPPEs Y134
TORC2 (rat) SSPYSPAYLSPPPES Y134
S136-p
PysPAyLsPPPESSW
3 58
TORC2 (human) PysPAyLsPPPESSW S136-p
TORC2 (mouse) PySPAYLsPPPEsGW S136-p
TORC2 (rat) PYSPAYLSPPPESGW S136
S141
yLsPPPESSWRRTMA
0 1
TORC2 (human) yLsPPPESSWRRTMA S141
TORC2 (mouse) YLsPPPEsGWRRMMP S141-p
TORC2 (rat) YLSPPPESGWRRMMP S141
K156-ub
WGNFPAEkGQLFrLP
0 1
TORC2 (human) WGNFPAEkGQLFrLP K156-ub
TORC2 (mouse) WGNLPAEKGQLFrLP K156
TORC2 (rat) WGNLPAEKGQLFRLP K156
K156-sm
WGNFPAEkGQLFrLP
0 1
TORC2 (human) WGNFPAEkGQLFrLP K156-sm
TORC2 (mouse) WGNLPAEKGQLFrLP K156
TORC2 (rat) WGNLPAEKGQLFRLP K156
R161-m2
AEkGQLFrLPsALNR
0 11
TORC2 (human) AEkGQLFrLPsALNR R161-m2
TORC2 (mouse) AEKGQLFrLPsALNR R161-m2
TORC2 (rat) AEKGQLFRLPSALNR R161
R161-m1
AEkGQLFrLPsALNR
0 11
TORC2 (human) AEkGQLFrLPsALNR R161-m1
TORC2 (mouse) AEKGQLFRLPsALNR R161
TORC2 (rat) AEKGQLFRLPSALNR R161
S164-p
GQLFrLPsALNRtss
0 13
TORC2 (human) GQLFrLPsALNRtss S164-p
TORC2 (mouse) GQLFrLPsALNRtSs S164-p
TORC2 (rat) GQLFRLPSALNRtss S164
T169-p
LPsALNRtssDsALH
0 14
TORC2 (human) LPsALNRtssDsALH T169-p
TORC2 (mouse) LPsALNRtSsDsALH T169-p
TORC2 (rat) LPSALNRtssDSALH T169-p
S170-p
PsALNRtssDsALHt
0 3
TORC2 (human) PsALNRtssDsALHt S170-p
TORC2 (mouse) PsALNRtSsDsALHT S170
TORC2 (rat) PSALNRtssDSALHT S170-p
S171-p
sALNRtssDsALHtS
Upstream
Downstream
19 22
Effects on Biological Processes:
  • transcription, inhibited
Treatment
  • phorbol_ester
  • VIP
  • virus infection
TORC2 (human) sALNRtssDsALHtS S171-p
TORC2 (mouse) sALNRtSsDsALHTs S171-p
TORC2 (rat) SALNRtssDSALHTS S171-p
S171
sALNRtsSDsALHtS
1 1
TORC2 (human) sALNRtsSDsALHtS S171
TORC2 (mouse) sALNRtSsDsALHTs S171-gl
TORC2 (rat) SALNRtsSDSALHTS S171
S173-p
LNRtssDsALHtSVM
0 2
TORC2 (human) LNRtssDsALHtSVM S173-p
TORC2 (mouse) LNRtSsDsALHTsVM S173-p
TORC2 (rat) LNRtssDSALHTSVM S173
S173
LNRtssDSALHtSVM
0 1
TORC2 (human) LNRtssDSALHtSVM S173
TORC2 (mouse) LNRtSsDsALHTsVM S173-gl
TORC2 (rat) LNRtssDSALHTSVM S173
T177-p
ssDsALHtSVMNPsP
0 1
TORC2 (human) ssDsALHtSVMNPsP T177-p
TORC2 (mouse) SsDsALHTsVMNPNP T177
TORC2 (rat) ssDSALHTSVMNPNP T177
S178
sDsALHtSVMNPsPQ
0 2
TORC2 (human) sDsALHtSVMNPsPQ S178
TORC2 (mouse) sDsALHTsVMNPNPQ S178-p
TORC2 (rat) sDSALHTSVMNPNPQ S178
S183-p
HtSVMNPsPQDtYPG
0 3
TORC2 (human) HtSVMNPsPQDtYPG S183-p
TORC2 (mouse) HTsVMNPNPQDtYPG N183
TORC2 (rat) HTSVMNPNPQDTYPG N183
T187-p
MNPsPQDtYPGPtPP
0 3
TORC2 (human) MNPsPQDtYPGPtPP T187-p
TORC2 (mouse) MNPNPQDtYPGPTPP T187-p
TORC2 (rat) MNPNPQDTYPGPTPP T187
T192-p
QDtYPGPtPPSILPS
0 1
TORC2 (human) QDtYPGPtPPSILPS T192-p
TORC2 (mouse) QDtYPGPTPPSVLPS T192
TORC2 (rat) QDTYPGPTPPSVLPS T192
R201-m1
PSILPSRrGGILDGE
0 1
TORC2 (human) PSILPSRrGGILDGE R201-m1
TORC2 (mouse) PSVLPSRRGGGFLDG R201
TORC2 (rat) PSVLPSRRGGFLDGE R201
K224-sm
EENLLDDkHLLkPWD
0 2
TORC2 (human) EENLLDDkHLLkPWD K224-sm
TORC2 (mouse) EENVVDDKHLLkPWD K225
TORC2 (rat) EENLVDDKHLLkPWD K224
K224-ub
EENLLDDkHLLkPWD
0 1
TORC2 (human) EENLLDDkHLLkPWD K224-ub
TORC2 (mouse) EENVVDDKHLLkPWD K225
TORC2 (rat) EENLVDDKHLLkPWD K224
K228-ac
LDDkHLLkPWDAkKL
Upstream
0 3
Treatment
  • vorinostat
TORC2 (human) LDDkHLLkPWDAkKL K228-ac
TORC2 (mouse) VDDKHLLkPWDAKKL K229-ac
TORC2 (rat) VDDKHLLkPWDAKKL K228-ac
K228-sm
LDDkHLLkPWDAkKL
0 1
TORC2 (human) LDDkHLLkPWDAkKL K228-sm
TORC2 (mouse) VDDKHLLKPWDAKKL K229
TORC2 (rat) VDDKHLLKPWDAKKL K228
K228-ub
LDDkHLLkPWDAkKL
0 1
TORC2 (human) LDDkHLLkPWDAkKL K228-ub
TORC2 (mouse) VDDKHLLKPWDAKKL K229
TORC2 (rat) VDDKHLLKPWDAKKL K228
K233-ub
LLkPWDAkKLSSsSS
0 1
TORC2 (human) LLkPWDAkKLSSsSS K233-ub
TORC2 (mouse) LLkPWDAKKLSSSSS K234
TORC2 (rat) LLkPWDAKKLSSSSS K233
S238-p
DAkKLSSsSSRPRsC
Upstream
Downstream
1 0
Effects on Modified Protein
  • intracellular localization
  • molecular association, regulation
  • phosphorylation
Effects on Biological Processes:
  • carcinogenesis, induced
  • cell growth, induced
  • cell motility, induced
  • transcription, induced
Putative in vivo kinases:
  • ERK2 (human)
Regulatory protein:
  • Akt2 (human)
  • CDK1 (human)
  • Mnk1 (human)
  • PKCA (human)
  • TBK1 (human)
Treatment
  • siRNA
TORC2 (human) DAkKLSSsSSRPRsC S238-p
TORC2 (mouse) DAKKLSSSSSRPRSC S239
TORC2 (rat) DAKKLSSSSSRPRSC S238
S244-p
SsSSRPRsCEVPGIN
1 0
TORC2 (human) SsSSRPRsCEVPGIN S244-p
TORC2 (mouse) SSSSRPRSCEVPGIN S245
TORC2 (rat) SSSSRPRSCEVPGIN S244
S274
PAMNTGGSLPDLTNL
6 0
TORC2 (human) PAMNTGGSLPDLTNL S274
TORC2 (mouse) PAMNTGGsLPDLTNL S275-p
TORC2 (rat) PAMSTGGSLPDLTNL S274
S306
PSLSGGNSTSNLTHT
2 1
TORC2 (human) PSLSGGNSTSNLTHT S306
TORC2 (mouse) PSLSGGNsTTNLTHT S307-p
TORC2 (rat) PSLSGGNSTTNLTHT S306
S336-p
YDAPGLHsPLSHPsL
0 2
TORC2 (human) YDAPGLHsPLSHPsL S336-p
TORC2 (mouse) YDVPGLHSPLSHPSL S337
TORC2 (rat) YDVPGLHSPLSHPSL S336
S342-p
HsPLSHPsLQSSLsN
0 1
TORC2 (human) HsPLSHPsLQSSLsN S342-p
TORC2 (mouse) HSPLSHPSLQSSLSN S343
TORC2 (rat) HSPLSHPSLQSSLSN S342
S348-p
PsLQSSLsNPNLQAS
0 3
TORC2 (human) PsLQSSLsNPNLQAS S348-p
TORC2 (mouse) PSLQSSLSNPNLQAS S349
TORC2 (rat) PSLQSSLSNPNLQAS S348
S366-p
PQPQLQGsHsHPSLP
0 1
TORC2 (human) PQPQLQGsHsHPSLP S366-p
TORC2 (mouse) PQPQLQGSHsHPSLP S367
TORC2 (rat) PQPQLQGSHSHPSLP S366
S368-p
PQLQGsHsHPSLPAS
2 7
TORC2 (human) PQLQGsHsHPSLPAS S368-p
TORC2 (mouse) PQLQGSHsHPSLPAS S369-p
TORC2 (rat) PQLQGSHSHPSLPAS S368
S386-p
RHVLPTTsLGHPsLs
0 1
TORC2 (human) RHVLPTTsLGHPsLs S386-p
TORC2 (mouse) HHALPTTSLGHPSLs S387
TORC2 (rat) HHALPTTSLGHPSLS S386
S391-p
TTsLGHPsLsAPALs
0 1
TORC2 (human) TTsLGHPsLsAPALs S391-p
TORC2 (mouse) TTSLGHPSLsAPALS S392
TORC2 (rat) TTSLGHPSLSAPALS S391
S393-p
sLGHPsLsAPALssS
0 7
TORC2 (human) sLGHPsLsAPALssS S393-p
TORC2 (mouse) SLGHPSLsAPALSSS S394-p
TORC2 (rat) SLGHPSLSAPALSSS S393
S398-p
sLsAPALssSSSSSS
0 1
TORC2 (human) sLsAPALssSSSSSS S398-p
TORC2 (mouse) SLsAPALSSSSSSSS S399
TORC2 (rat) SLSAPALSSSSSSSS S398
S399-p
LsAPALssSSSSSST
0 1
TORC2 (human) LsAPALssSSSSSST S399-p
TORC2 (mouse) LsAPALSSSSSSSST S400
TORC2 (rat) LSAPALSSSSSSSST S399
S419-p
GAPSYPAsTPGAsPH
0 1
TORC2 (human) GAPSYPAsTPGAsPH S419-p
TORC2 (mouse) SAPPYPASTPGASPR S420
TORC2 (rat) SAPPYPASTPGASPR S419
S424-p
PAsTPGAsPHHRRVP
0 2
TORC2 (human) PAsTPGAsPHHRRVP S424-p
TORC2 (mouse) PASTPGASPRHRRVP S425
TORC2 (rat) PASTPGASPRHRRVP S424
S433-p
HHRRVPLsPLsLLAG
Upstream
1 114
Kinase, in vitro:
  • CDK2 (human)
Treatment
  • antibody
  • ischemia
  • LRRK2-IN-1
  • metastatic potential
  • selumetinib
  • vemurafenib
TORC2 (human) HHRRVPLsPLsLLAG S433-p
TORC2 (mouse) RHRRVPLsPLsLPAG S434-p
TORC2 (rat) RHRRVPLSPLSLPAG S433
S436-p
RVPLsPLsLLAGPAD
0 5
TORC2 (human) RVPLsPLsLLAGPAD S436-p
TORC2 (mouse) RVPLsPLsLPAGPAD S437-p
TORC2 (rat) RVPLSPLSLPAGPAD S436
S447-p
GPADARRsQQQLPkQ
0 14
TORC2 (human) GPADARRsQQQLPkQ S447-p
TORC2 (mouse) GPADARRSQQQLPKQ S448
TORC2 (rat) GPADARRSQQQLPKQ S447
K453-sm
RsQQQLPkQFsPtMs
0 1
TORC2 (human) RsQQQLPkQFsPtMs K453-sm
TORC2 (mouse) RSQQQLPKQFsPtMS K454
TORC2 (rat) RSQQQLPKQFsPTMs K453
S456-p
QQLPkQFsPtMsPTL
Upstream
0 12
Treatment
  • nocodazole
TORC2 (human) QQLPkQFsPtMsPTL S456-p
TORC2 (mouse) QQLPKQFsPtMSPtL S457-p
TORC2 (rat) QQLPKQFsPTMsPTL S456-p
T458-p
LPkQFsPtMsPTLSS
0 2
TORC2 (human) LPkQFsPtMsPTLSS T458-p
TORC2 (mouse) LPKQFsPtMSPtLSS T459-p
TORC2 (rat) LPKQFsPTMsPTLSS T458
S460-p
kQFsPtMsPTLSSIT
Upstream
0 6
Treatment
  • nocodazole
TORC2 (human) kQFsPtMsPTLSSIT S460-p
TORC2 (mouse) KQFsPtMSPtLSSIT S461
TORC2 (rat) KQFsPTMsPTLSSIT S460-p
T462
FsPtMsPTLSSITQG
0 1
TORC2 (human) FsPtMsPTLSSITQG T462
TORC2 (mouse) FsPtMSPtLSSITQG T463-p
TORC2 (rat) FsPTMsPTLSSITQG T462
Y488-p
QRLPPYPyssPsLVL
0 6
TORC2 (human) QRLPPYPyssPsLVL Y488-p
TORC2 (mouse) QRLPPYPysPPsLVI Y489-p
TORC2 (rat) QRLPPYPYSPPSLVI Y488
S489-p
RLPPYPyssPsLVLP
Upstream
0 15
Treatment
  • nocodazole
TORC2 (human) RLPPYPyssPsLVLP S489-p
TORC2 (mouse) RLPPYPysPPsLVIP S490-p
TORC2 (rat) RLPPYPYSPPSLVIP S489
S490-p
LPPYPyssPsLVLPt
0 4
TORC2 (human) LPPYPyssPsLVLPt S490-p
TORC2 (mouse) LPPYPysPPsLVIPT P491
TORC2 (rat) LPPYPYSPPSLVIPS P490
S492-p
PYPyssPsLVLPtQP
0 13
TORC2 (human) PYPyssPsLVLPtQP S492-p
TORC2 (mouse) PYPysPPsLVIPTHP S493-p
TORC2 (rat) PYPYSPPSLVIPSHP S492
T497-p
sPsLVLPtQPHtPKs
0 4
TORC2 (human) sPsLVLPtQPHtPKs T497-p
TORC2 (mouse) PPsLVIPTHPPtPKS T498
TORC2 (rat) PPSLVIPSHPPTPKS S497
T501-p
VLPtQPHtPKsLQQP
Upstream
0 22
Treatment
  • ischemia
  • nocodazole
  • Y27632
TORC2 (human) VLPtQPHtPKsLQQP T501-p
TORC2 (mouse) VIPTHPPtPKSLQQL T502-p
TORC2 (rat) VIPSHPPTPKSLQQL T501
S504-p
tQPHtPKsLQQPGLP
0 1
TORC2 (human) tQPHtPKsLQQPGLP S504-p
TORC2 (mouse) THPPtPKSLQQLPSQ S505
TORC2 (rat) SHPPTPKSLQQLPSQ S504
S519-p
SQSCSVQsSGGQPPG
0 1
TORC2 (human) SQSCSVQsSGGQPPG S519-p
TORC2 (mouse) SQACLVQPSGGQPPG P518
TORC2 (rat) SQACLVQPSGGQPPG P517
S613-p
THCSRHGsGPNIILt
Upstream
0 40
Treatment
  • dasatinib
  • ischemia
  • nocodazole
TORC2 (human) THCSRHGsGPNIILt S613-p
TORC2 (mouse) THCSRHGsGPNIILT S612-p
TORC2 (rat) THCSRHGsGPNIILT S611-p
T620-p
sGPNIILtGDssPGF
0 2
TORC2 (human) sGPNIILtGDssPGF T620-p
TORC2 (mouse) sGPNIILTGDssPGF T619
TORC2 (rat) sGPNIILTGDsSPGF T618
S623-p
NIILtGDssPGFsKE
0 8
TORC2 (human) NIILtGDssPGFsKE S623-p
TORC2 (mouse) NIILTGDssPGFskE S622-p
TORC2 (rat) NIILTGDsSPGFSKE S621-p
S624-p
IILtGDssPGFsKEI
Upstream
0 25
Treatment
  • nocodazole
TORC2 (human) IILtGDssPGFsKEI S624-p
TORC2 (mouse) IILTGDssPGFskEI S623-p
TORC2 (rat) IILTGDsSPGFSKEI S622
S628-p
GDssPGFsKEIAAAL
0 2
TORC2 (human) GDssPGFsKEIAAAL S628-p
TORC2 (mouse) GDssPGFskEIAAAL S627-p
TORC2 (rat) GDsSPGFSKEIAAAL S626
K629
DssPGFsKEIAAALA
1 0
TORC2 (human) DssPGFsKEIAAALA K629
TORC2 (mouse) DssPGFskEIAAALA K628-ac
TORC2 (rat) DsSPGFSKEIAAALA K627
K629
DssPGFsKEIAAALA
1 0
TORC2 (human) DssPGFsKEIAAALA K629
TORC2 (mouse) DssPGFskEIAAALA K628-ub
TORC2 (rat) DsSPGFSKEIAAALA K627